Articles with public access mandates - Jurgen RehmLearn more
OverallCIHRNIHGovernment of SpainMRCNIHRNHMRCEuropean CommissionNSERCGatesWellcomeSSHRCDFGSNSFSwedish Research CouncilCCSCancer Research UKBMBFBHFFRQSFCTMSFHRDFFINSERMKnut and Alice Wallenberg FoundationESRCWHOZonMwGovernment of ItalyNSFUSAIDHSFDNRFAcademy of FinlandWellcome Trust/DBT India AllianceFORTEBBSRCCSOEPSRCNRFDoris Duke Charitable FoundationANRSCLUK Research & InnovationWorld Cancer Researh Fund, UKMedical Research Future Fund, AustraliaMinistry of Business Innovation and Employment
Not available anywhere: 61
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4
M Bennett, J.E., Stevens, G.A., Mathers, C.D., Bonita, R., Rehm, J., Kruk, M ...
Lancet 392 (10152), 1072-1088, 2018
Mandates: UK Medical Research Council, Wellcome Trust
Alcohol use disorders
AF Carvalho, M Heilig, A Perez, C Probst, J Rehm
The Lancet 394 (10200), 781-792, 2019
Mandates: Canadian Institutes of Health Research, Swedish Research Council
Cancer incidence and mortality attributable to alcohol consumption
D Praud, M Rota, J Rehm, K Shield, W Zatoński, M Hashibe, C La Vecchia, ...
International journal of cancer 138 (6), 1380-1387, 2016
Mandates: US National Institutes of Health, Government of Italy
Non‐medical use of prescription opioids and prescription opioid‐related harms: why so markedly higher in N orth A merica compared to the rest of the world?
B Fischer, A Keates, G Bühringer, J Reimer, J Rehm
Addiction 109 (2), 177-181, 2014
Mandates: Canadian Institutes of Health Research
Health outcomes associated with crack-cocaine use: Systematic review and meta-analyses
AJ Butler, J Rehm, B Fischer
Drug and Alcohol Dependence 180, 401-416, 2017
Mandates: Canadian Institutes of Health Research
Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates
S Lev-Ran, B Le Foll, K McKenzie, TP George, J Rehm
Psychiatry research 209 (3), 459-465, 2013
Mandates: Canadian Institutes of Health Research
Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment …
EM Goldner, A Lusted, M Roerecke, J Rehm, B Fischer
Addictive behaviors 39 (3), 520-531, 2014
Mandates: Canadian Institutes of Health Research
Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions
S Lev-Ran, S Imtiaz, BJ Taylor, KD Shield, J Rehm, B Le Foll
Drug and alcohol dependence 123 (1-3), 190-200, 2012
Mandates: Canadian Institutes of Health Research
High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005–2009
B Fischer, W Jones, J Rehm
Pharmacoepidemiology and drug safety 22 (4), 438-442, 2013
Mandates: Canadian Institutes of Health Research
Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in O ntario, C anada, 2005–2011
B Fischer, W Jones, K Urbanoski, R Skinner, J Rehm
Drug and alcohol review 33 (1), 19-26, 2014
Mandates: Canadian Institutes of Health Research
Differences and over‐time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005–2010
B Fischer, W Jones, M Krahn, J Rehm
Pharmacoepidemiology and drug safety 20 (12), 1269-1277, 2011
Mandates: Canadian Institutes of Health Research
The ‘fentanyl epidemic’in Canada–some cautionary observations focusing on opioid-related mortality
B Fischer, L Vojtila, J Rehm
Preventive medicine 107, 109-113, 2018
Mandates: Canadian Institutes of Health Research
Risk and speed of transitions to first alcohol dependence symptoms in adolescents: a 10‐year longitudinal community study in Germany
S Behrendt, HU Wittchen, M Höfler, R Lieb, NCP Low, J Rehm, K Beesdo
Addiction 103 (10), 1638-1647, 2008
Mandates: German Research Foundation
Prevalence and key covariates of non‐medical prescription opioid use among the general secondary student and adult populations in O ntario, C anada
B Fischer, A Ialomiteanu, A Boak, E Adlaf, J Rehm, RE Mann
Drug and alcohol review 32 (3), 276-287, 2013
Mandates: Canadian Institutes of Health Research
The standard joint unit
CC Kögel, MM Balcells-Olivero, H López-Pelayo, L Miquel, L Teixido, ...
Drug and Alcohol Dependence 176, 109-116, 2017
Mandates: Government of Spain
Are trends in alcohol consumption and cause-specific mortality in Russia between 1990 and 2017 the result of alcohol policy measures?
A Nemtsov, M Neufeld, J Rehm
Journal of studies on alcohol and drugs 80 (5), 489-498, 2019
Mandates: Federal Ministry of Education and Research, Germany
Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004–2009
B Fischer, N Nakamura, B Rush, J Rehm, K Urbanoski
Drug and alcohol dependence 109 (1-3), 257-260, 2010
Mandates: Canadian Institutes of Health Research
Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects
B Brands, RE Mann, CM Wickens, B Sproule, G Stoduto, GS Sayer, ...
Drug and alcohol dependence 205, 107641, 2019
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Effectiveness of policy changes to reduce harm from unrecorded alcohol in Russia between 2005 and now
M Neufeld, J Rehm
International Journal of Drug Policy 51, 1-9, 2018
Mandates: Federal Ministry of Education and Research, Germany
Cannabis use and mental health-related quality of life among individuals with anxiety disorders
S Lev-Ran, B Le Foll, K McKenzie, J Rehm
Journal of anxiety disorders 26 (8), 799-810, 2012
Mandates: Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program